German medtech company founded 2002 in Kissing that developed the first single-use robotically-assisted HD colonoscope; acquired by Ambu in 2017 for EUR 225M.
invendo medical GmbH, headquartered in Kissing, Bavaria, Germany, was founded in 2002 to address cross-contamination risks in conventional reusable gastrointestinal endoscopy. The company developed the Invendoscope, the world's first single-use, robotically-assisted high-definition colonoscope platform, eliminating endoscope reprocessing and reducing infection risk. The Invendoscope uses a motor-driven propulsion system that allows precise, robotic advancement of the scope through the colon, reducing patient discomfort and procedure time.
The device received CE marking and FDA 510(k) clearance, targeting the global market of approximately 70 million annual gastroenterology procedures. In October 2017, Ambu A/S acquired invendo medical GmbH for EUR 225 million (EUR 115 million upfront plus contingent payments up to EUR 110 million), integrating its single-use endoscopy technology into Ambu's broader portfolio of single-use visualization devices for gastroenterology.
Primary type & automation activities this supplier delivers:
Single-use, motor-driven robotically-assisted HD colonoscope that eliminates reprocessing and reduces cross-contamination risk in gastrointestinal endoscopy.
Contact invendo medical GmbH
WEBSITE
https://www.ambu.comPHONE
+45 7225 2000HEADQUARTERS
Denmark
Company Facts
Founded
2002
Primary Role
Manufacturer
Company Size
-
Primary Region
Europe
Annual Sales
-
Funding Stage
-
Funding Total
-
Certifications & Memberships